Ophthalmology Services in New Jersey
Steven B. Cohen, M.D. and Eric D. Kanter, M.D. are board certified by the American Board of Ophthalmology and are fellowship trained in the diagnosis and treatment of retinal and macular diseases and vitreoretinal surgery.
Dr. Cohen and Dr. Kanter have been selected as The Best Doctors in New York Magazine and New Jersey Monthly Magazine. They have also been selected as Top Doctors as featured in Castle Connolly Reports and selected as Best Doctors in America and Top Ophthalmologists in America.
Retina-Vitreous Consultants' scope of practice is limited to consultation, laser surgical intervention, and intraocular surgical rehabilitation of vision loss secondary to diseases of the retina, vitreous, and macula. These conditions include diabetic eye disease, macular degeneration, retinal tears and detachments, ocular inflammation (uveitis), macular surface anomalies, such as macular holes and puckers, retinal vascular diseases, and hereditary and juvenile retinal degenerative conditions and dystrophies.
Our Retinal Imaging Center offers digital real time fluorescein and ICG angiography, ocular ultrasound, and optical coherence tomography for immediate review by Dr. Cohen or Dr. Kanter to determine a patient's course of treatment. OCT is an invaluable tool in the diagnosis of retinal disease and allows for two-dimensional quantitative and volumetric analysis of a patient's clinical response to laser, surgical, and pharmacotherapeutic treatments.
Retina-Vitreous Consultants is an active participant in national collaborative clinical research trials investigating the effects of various drug therapies, laser modalities, and surgical interventions in the treatment of patients with diabetic retinopathy and macular degeneration.
We have been recognized by our peers for our expertise in being the only retinal practice in Northern New Jersey to be certified by the world renowned Harvard affiliated Joslin Center for Diabetes in Boston.
To schedule a consultation with Dr. Cohen or Dr. Kanter or to learn more about our practice, services, or an individual's potential eligibility for enrollment in any of our current clinical research protocols, please call 973.716.0123.
back to top